RenovoRx, Inc. (RNXT) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts RNXT Hot Sheet
Join SI Premium – FREE
RenovoRx, Inc. (NASDAQ: RNXT) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on RenovoRx, Inc. (RNXT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hesai Group (HSAI) Tops Q1 EPS by 8c
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Goldman Sachs updates view on protein markets ahead of earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
